Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 401 citing articles:

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang, Hengyou Weng, Jianjun Chen
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 270-288
Open Access | Times Cited: 923
The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang, Shan Kong, Mei Tao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 788
The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 467
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 419
The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Paz Nombela, Borja Miguel‐López, Sandra Blanco
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 352
m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
Dan Jin, Jiwei Guo, Yan Wu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 273
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
Weijun Wan, Xiang Ao, Quan Chen, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 267
Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer
Bela Goyal, Shashi Ranjan Mani Yadav, Nikee Awasthee, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188502-188502
Closed Access | Times Cited: 260
METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer
Xiaoxiang Chen, Mu Xu, Xueni Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 259
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 256
N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
Zhenchuan Liu, Tingting Wang, Yunlang She, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 251
m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao, Yuanfei Shi, Huafei Shen, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 243
Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 224
Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
Yi Chen, Lin Yu, Yongqian Shu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 220
Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
You-Cai Yi, Xiaoyu Chen, Jing Zhang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 191
Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 172
LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression
Tong Sun, Zhikun Wu, Xiufang Wang, et al.
Oncogene (2020) Vol. 39, Iss. 31, pp. 5358-5372
Closed Access | Times Cited: 166
METTL3 plays multiple functions in biological processes.
Shuiping Liu, Lvjia Zhuo, Jianjun Wang, et al.
PubMed (2020) Vol. 10, Iss. 6, pp. 1631-1646
Closed Access | Times Cited: 158
m6A transferase METTL3‐induced lncRNA ABHD11‐AS1 promotes the Warburg effect of non‐small‐cell lung cancer
Lei Xue, Jun Li, Yi-Hui Lin, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2649-2658
Closed Access | Times Cited: 142
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 140
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 138
Circ0008399 Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer
Wenjie Wei, Jiayin Sun, Hui Zhang, et al.
Cancer Research (2021) Vol. 81, Iss. 24, pp. 6142-6156
Open Access | Times Cited: 131
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
Yueqin Sun, Weitao Shen, Shulu Hu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 120
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner
Xiaoping Pan, Xiaolv Hong, Sumei Li, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 1, pp. 91-102
Open Access | Times Cited: 119
Page 1 - Next Page

Scroll to top